Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Tscan Therapeutics Inc (TCRX)

Tscan Therapeutics Inc (TCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 74,134
  • Shares Outstanding, K 56,591
  • Annual Sales, $ 2,820 K
  • Annual Income, $ -127,500 K
  • EBIT $ -140 M
  • EBITDA $ -136 M
  • 60-Month Beta 1.06
  • Price/Sales 25.72
  • Price/Cash Flow N/A
  • Price/Book 0.34

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/25
See More
  • Average Estimate -0.28
  • Number of Estimates 3
  • High Estimate -0.26
  • Low Estimate -0.30
  • Prior Year -0.28
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.2200 +1.64%
on 05/14/25
1.7300 -28.32%
on 04/24/25
-0.0600 (-4.62%)
since 04/16/25
3-Month
1.0200 +21.57%
on 04/09/25
2.3300 -46.78%
on 02/21/25
-0.8100 (-39.51%)
since 02/14/25
52-Week
1.0200 +21.57%
on 04/09/25
9.6900 -87.20%
on 05/21/24
-7.6600 (-86.07%)
since 05/16/24

Most Recent Stories

More News
TScan Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update

TCRX : 1.2400 (-5.34%)
TScan Therapeutics Announces Upcoming Presentation at the American Society of Gene and Cell Therapy 28th Annual Meeting

TCRX : 1.2400 (-5.34%)
TScan Therapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference

TCRX : 1.2400 (-5.34%)
TScan Therapeutics Appoints Commercial Leader Stephen Camiolo as Senior Vice President, Market Access

TCRX : 1.2400 (-5.34%)
TScan Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

TCRX : 1.2400 (-5.34%)
TScan Therapeutics Announces Upcoming Presentation at the TD Cowen 45th Annual Health Care Conference

TCRX : 1.2400 (-5.34%)
TScan Therapeutics to Participate in the H.C. Wainwright 3rd Annual Cell Therapy Virtual Conference

TCRX : 1.2400 (-5.34%)
TScan Therapeutics Announces $30 Million Registered Direct Offering at a 37% Premium

TCRX : 1.2400 (-5.34%)
TScan Therapeutics Refinances Existing Convertible Debt Facility with Term Loan for up to $52.5 Million from Silicon Valley Bank

TCRX : 1.2400 (-5.34%)
2 "Strong Buy"-Rated Biotech Stocks With 303% to 446% Upside Potential

While the upside is appealing, penny stocks carry some risks.

TCRX : 1.2400 (-5.34%)
$SPX : 5,958.38 (+0.70%)
SCPH : 3.22 (+11.81%)

Business Summary

TScan Therapeutics Inc. is a biopharmaceutical company. It focused on the development of T-cell receptor engineered T cell therapies for the treatment of patients with cancer. The company's lead product pipeline consist TSC-100 and TSC-101. TScan Therapeutics Inc. is based in WALTHAM, Mass.

See More

Key Turning Points

3rd Resistance Point 1.4017
2nd Resistance Point 1.3633
1st Resistance Point 1.3017
Last Price 1.2400
1st Support Level 1.2017
2nd Support Level 1.1633
3rd Support Level 1.1017

See More

52-Week High 9.6900
Fibonacci 61.8% 6.3781
Fibonacci 50% 5.3550
Fibonacci 38.2% 4.3319
Last Price 1.2400
52-Week Low 1.0200

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar